Balance between MKK6 and MKK3 Mediates p38 MAPK Associated Resistance to Cisplatin in NSCLCEva María Galán‐Moya, Ricardo Sánchez‐Prieto|PLoS ONE|2011Cited by 40
c‐Abl activates p38 MAPK independently of its tyrosine kinase activity: Implications in cisplatin‐based therapyEva María Galán‐Moya, Ricardo Sánchez‐Prieto|International Journal of Cancer|2007Cited by 37